Protecting the rights of investigators in industry-supported clinical research

Journal of Vascular Surgery

Volumn 35, Issue 5, 2002, Pages 1036-1040

  Rutherford, Robert B ^a   Johnston, K Wayne ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIVIL RIGHTS; CLINICAL RESEARCH; EDITORIAL; MEDICAL LITERATURE; PRIORITY JOURNAL; SCIENTIST; DRUG INDUSTRY; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; HUMAN RIGHTS; LEGAL ASPECT; PERSONNEL;

DRUG INDUSTRY; HUMAN RIGHTS; HUMANS; RESEARCH PERSONNEL; RESEARCH SUPPORT;

EID: 0036583042     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.123718     Document Type: Article

References (13)

1. Rutherford RB. Problems with the dissemination of up-to-date-information on the results ofendograft repair for abdominal aortic aneurysm. J Vasc Surg 1999;29:1167-97
2. Rutherford RB, Johnston KW. Potential problems with industry-supported research. J Vasc Surg 2000;31:1066-76.
3. Weatherall D. Academia and industry: increasingly uneasy bedfellows. Lancet 2000;355:1574.
4. Angell M. Is academic medicine for sale? N Eng J Med 2000;342:1516-8.
5. Bodenheimer T. Uneasy alliance-clinical investigators and the pharmaceutical industry. N Eng J Med 2000;342:1539-44.
6. Goldstein LB, Brott TG, Kothari RU, Smith WS. Clinical stroke trials: guarding against bias. Stroke 1999;30:1165-7.
7. Hailey D. Scientific harassment by pharmaceutical companies: time to stop. CMAJ 2000;162:212-3.
8. Rennie D. Fair conduct and fair reporting of clinical trials. JAMA 1999;282:1766-8.
9. 6/L CD4 cell counts: a randomized controlled trial. JAMA 2000;284:2193-202.
10. Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS. Withholding research results in academic life science: evidence from a national survey of faculty. JAMA 1997;277:1224-8.
11. Etchells E, McLeod RS, Greets W, Barton P, Detsky AS. Economic analysis of low-dose heparin vs. the low-moleculard heparin Enoxaparin for prevention of venous thromboembolism after colorectal surgery. Arch Int Med 1999;159:1221-8.
12. Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard, Lhorton R, et al. Sponsorship, authorship, and accountability. N Engl J Med 2001;345:825.
13. Johnston KW, Rutherford RB. Policy on declaring conditions of funding for research studies. J Vasc Surg 2002;35:197.